NOBELPHARMA AB – Trademark Portfolio
Entity Type: 03
NOBELPHARMA AB holds 30 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 23 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 6 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include BAHA, MYERSON, VI-COMP, MYERSON'S, and NOBEL BIOCARE. The owner is based in S402 26, GOTEBORG.
BOX 5190
S402 26, GOTEBORG , SE
Showing of trademarks Trademarks
Trademark Classifications
NOBELPHARMA AB's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does NOBELPHARMA AB have?
NOBELPHARMA AB has 30 U.S. trademarks filed with the USPTO. Of these, 6 registered, 9 abandoned, 15 cancelled.
What trademark classes does NOBELPHARMA AB file in?
NOBELPHARMA AB files trademarks across 6 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are NOBELPHARMA AB's most well-known trademarks?
NOBELPHARMA AB's registered trademark portfolio includes well-known marks such as BAHA, MYERSON, VI-COMP, MYERSON'S, and NOBEL BIOCARE. These are among 6 currently registered trademarks in the portfolio.
What is NOBELPHARMA AB's trademark registration success rate?
NOBELPHARMA AB has a 20% trademark registration rate, with 6 out of 30 resolved applications resulting in successful registration. Currently, 0 applications are pending review.